(Q33403813)

26 July 2017

High-dose cisplatin in disseminated melanoma: a comparison of two schedules (English)

1 reference

26 July 2017

1 reference

J E Mortimer

1

1 reference

26 July 2017

S Schulman

2

1 reference

26 July 2017

J S MacDonald

3

1 reference

26 July 2017

K Kopecky

4

1 reference

26 July 2017

G Goodman

5

1 reference

26 July 2017

1 January 1990

1 reference

Cancer Chemotherapy and Pharmacology

26 July 2017

1 reference

26 July 2017

25

1 reference

26 July 2017

5

1 reference

26 July 2017

373-376

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00686241

26 July 2017

0 references

cites work

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer

1 reference

12 December 2020

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

1 reference

12 December 2020

cis-Platinum-induced hypomagnesemia and peripheral neuropathy

1 reference

12 December 2020

Regression of regionally advanced melanoma after arterial infusion with cis-platinum and actinomycin-D

1 reference

12 December 2020

DTIC (NSC-45388) in malignant melanoma: a perspective

1 reference

12 December 2020

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

1 reference

12 December 2020

High-dose platinum for the treatment of refractory ovarian cancer

1 reference

12 December 2020

Regression of regionally confined melanoma with intra-arterial cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study

1 reference

12 December 2020

High-Dose Cisplatin in Hypertonic Saline

1 reference

12 December 2020

Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma

1 reference

12 December 2020

High-dose cisplatin in advanced head and neck cancer

1 reference

12 December 2020

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

1 reference

12 December 2020

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686241

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference